BEHIND THE DEAL: Why Medtronic And Qualcomm Are Teaming Up On Diabetes

Diabetes might be Medtronic’s smallest business division in terms of revenue but its growth rates are far from stunted, having recorded the top-line increases of 6% for both the fourth fiscal quarter and full fiscal year 2016.

More from Business

More from Medtech Insight